Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma

Journal of the National Cancer Institute

Volumn 91, Issue 9, 1999, Pages 790-796

  Horiuchi, Akiko ^a   Nikaido, Toshio ^a   Taniguchi, Shunichiro ^a   Fujii, Shingo ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; CALPONIN; CALPONIN H1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LEIOMYOSARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE CONTRACTION; UTERUS SARCOMA;

EID: 0033526397     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.9.790     Document Type: Article

References (39)

1. Zaloudek C, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. New York (NY): Springer-Verlag; 1994. p. 487-528.
2. Horiuchi A, Nikaido T, Ito K, Zhai Y, Orii A, Taniguchi S, et al. Reduced expression of calponin h1 in leiomyosarcoma of the uterus. Lab Invest 1998;78:839-46.
3. Amada S, Nakano H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 1995;14:134-42.
4. Miettinen M, Lehto VP, Ekblom P, Tasanen A, Virtanen I. Leiomyosarcoma of the mandible: diagnosis as aided by immunohistochemical demonstration of desmin and laminin. J Oral Pathol 1984;13:373-81.
5. Sprogoe-Jakobsen S, Holund B. Immunohistochemistry (Ki-67 and p53) as a tool in determining malignancy in smooth muscle neoplasms (exemplified by a myxoid leiomyosarcoma of the uterus). APMIS 1996;104:705-8.
6. Trzyna W, McHugh M, McCue P, McHugh KM. Molecular determination of the malignant potential of smooth muscle neoplasms. Cancer 1997;80:211-7.
7. Takahashi K, Hiwada K, Kokubu T. Isolation and characterization of a 34,000-dalton calmodulin- and F-actin-binding protein from chicken gizzard smooth muscle. Biochem Biophys Res Commun 1986;141:20-6.
8. Takahashi K, Hiwada K, Kokubu T. Vascular smooth muscle calponin. A novel troponin T-like protein. Hypertension 1998;11:620-6.
9. Takahashi K, Nadal-Ginard B. Molecular cloning and sequence analysis of smooth muscle calponin [published erratum appears in J Biol Chem 1992;267:26198]. J Biol Chem 1991; 266:13284-8.
10. Strasser P, Gimona M, Moessler H, Herzog M, Small JV. Mammalian calponin. Identification and expression of genetic variants. FEBS Lett 1993;330:13-8.
11. Gimona M, Herzog M, Vandekerckhove J, Small JV. Smooth muscle specific expression of calponin. FEBS Lett 1990;274:159-62.
12. Winder SJ, Walsh MP. Smooth muscle calponin. Inhibition of actomyosin MgATPase and regulation by phosphorylation. J Biol Chem 1990;265:10148-55.
13. Winder SJ, Walsh MP. Structural and functional characterization of calponin fragments. Biochem Int 1990;22:335-41.
14. Winder SJ, Walsh MP, Vasulka C, Johnson JD. Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases. Biochemistry 1993;32:13327-33.
15. Wills FL, McCubbin WD, Kay CM. Smooth muscle calponin-caltropin interaction: effect on biological activity and stability of calponin. Biochemistry 1994;33:5562-9.
16. Takahashi K, Tkagi M, Ohgami K, Nakai M, Kojima A, Nadal-Ginard B, et al. Inhibition of smooth muscle cell migration and proliferation caused by transfection of the human calponin gene is associated with enhanced cell matrix adhesion and reduced PDGF responsiveness [abstract]. Circulation 1993;88:1-174.
17. Takahashi K, Miwa A, Tkagi M, Kojima A, Eshita Y, Nara Y, et al. Overexpression of calponin in transgenic rats inhibits intimal arterial smooth muscle cell hyperplasia in the carotid artery model of restenosis [abstract]. Circulation 1995;92:1-295.
18. Samaha FF, Ip HS, Morrisey E, Seltzer J, Tang Z, Solway J, et al. Developmental pattern of expression and genomic organization of the calponin-h1 gene. A contractile smooth muscle cell marker. J Biol Chem 1996;271:395-403.
19. Miano JM, Olson EN. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis [published erratum appears in J Biol Chem 1997;272:27492]. J Biol Chem 1996;271:7095-103.
20. Ishiwata I, Nozawa S, Nagai S, Kurihara S, Mikata A. Establishment of a human leiomyosarcoma cell line. Cancer Res 1977;37:658-64.
21. Fogh J, Trempe G. Human tumor cells in vitro. In: Fogh J, editor. New York (NY): Plenum Press; 1975. p. 115-59.
22. Maguchi M, Nishida W, Kohara K, Kuwano A, Kondo I, Hiwada K. Molecular cloning and gene mapping of human basic and acidic calponins. Biochem Biophys Res Commun 1995; 217:238-44.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1887;162:156-9.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytoxicity assays. J Immunol Methods 1983;65:55-63.
25. Tomas DG, Gart JJ. Improved and extended exact and asymptotic methods for the combination of 2 x 2 tables. Comput Biomed Res 1992;25:75-84.
26. Negoro N, Fukui R, Tsuchikane E, Otsuji S, Kato O, Kobayashi T, et al. Down-expression of calponin in smooth muscle of coronary artery lesions identifies a group of lesions at high risk for restenosis after atherectomy: implications for human gene therapy by direct calponin gene transfer [abstract]. Circulation 1994; 90:1-142.
27. Jiang Z, Grange RW, Walsh MP, Kamm KE. Adenovirus-mediated transfer of the smooth muscle cell calponin gene inhibits proliferation of smooth muscle cells and fibroblasts. FEBS Lett 1997;413:441-5.
28. Folkman J, Moscona A. Role of cell shape in growth control. Nature 1978;273:345-9.
29. Guadagno TM, Ohtsubo M, Roberts JM, Assoian RK. A link between cyclin A expression and adhesion-dependent cell cycle progression [published erratum appears in Science 1994; 263:455]. Science 1993;262:1572-5.
30. Kake T, Kimura S, Takahashi K, Maruyama K. Calponin induces actin polymerization at low ionic strength and inhibits depolymerization of actin filaments. Biochem J 1995;312(Pt 2): 587-92.
31. Winder SJ, Walsh MP. Calponin: thin filament-linked regulation of smooth muscle contraction. Cell Signal 1993;5:677-86.
32. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362: 801-9.
33. Fayed YM, Tsibris JC, Langenberg PW, Robertson AL Jr. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest 1989;60:30-7.
34. Koutsilieris M, Elmeliani D, Frenette G, Maheux R. Leiomyoma-derived growth factors for smooth muscle cells. In Vivo 1992;6:579-85.
35. Sourla A, Koutsilieris M. Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts. J Clin Invest 1995;96:751-8.
36. van der Ven LT, Gloudemans T, Roholl PJ, van Buul-Offers SC, Bladergroen BA, Welters MJ, et al. Growth advantage of human leiomyoma cells compared to normal smooth-muscle cells due to enhanced sensitivity toward insulin-like growth factor I. Int J Cancer 1994;59: 427-34.
37. Kumar CC, Kim JH, Bushel P, Armstrong L, Catino JJ. Activation of smooth muscle α-actin promoter in ras-transformed cells by treatments with antimitotic agents: correlation with stimulation of SRF:SRE mediated gene transcription. J Biochem (Tokyo) 1995;118:1285-92.
38. Leavitt J, Gunning P, Kedes L, Jariwalla R. Smooth muscle alpha-actin is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells. Nature 1985;316:840-2.
39. Takahashi K, Tazunoki T, Okada T, Ohgami K, Miwa T, Miki A, et al The 5′-flanking region of the human smooth muscle cell calponin gene contains a cis-acting domain for interaction with a methylated DNA-binding transcription represser. J Biochem (Tokyo) 1996;120: 18-21.